These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 12749753)

  • 1. Stealth nucleosides: mode of action and potential use in the treatment of viral diseases.
    Daifuku R
    BioDrugs; 2003; 17(3):169-77. PubMed ID: 12749753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC; Evans DH
    Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral error catastrophe by mutagenic nucleosides.
    Anderson JP; Daifuku R; Loeb LA
    Annu Rev Microbiol; 2004; 58():183-205. PubMed ID: 15487935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclic nucleoside phosphonates: a new dimension to the chemotherapy of DNA virus and retrovirus infections.
    De Clercq E
    J Med Microbiol; 1998 Jan; 47(1):1-3. PubMed ID: 9449944
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiviral drug discovery and development: where chemistry meets with biomedicine.
    De Clercq E
    Antiviral Res; 2005 Aug; 67(2):56-75. PubMed ID: 16046240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hamao Umezawa Memorial Award Lecture: "An Odyssey in the Viral Chemotherapy Field".
    De Clercq E
    Int J Antimicrob Agents; 2001 Oct; 18(4):309-28. PubMed ID: 11691563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.
    Miller V; Larder BA
    Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The future of antivirals: broad-spectrum inhibitors.
    Debing Y; Neyts J; Delang L
    Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.
    Qiu L; Patterson SE; Bonnac LF; Geraghty RJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006421. PubMed ID: 29672522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal mutagenesis of HIV with mutagenic nucleoside analogs.
    Loeb LA; Essigmann JM; Kazazi F; Zhang J; Rose KD; Mullins JI
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1492-7. PubMed ID: 9990051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Nucleosides and Non-nucleosides Based 4,6-disubstituted-2-oxo-dihydropyridine-3-carbonitriles as Antiviral Agents.
    Ibrahim TS; El-Sayed HA; Khayat MT; Al-Mahmoudy AMM; Moustafa AH; El-Deen AKS; Rostom SAF; Panda SS
    Med Chem; 2018; 14(8):791-808. PubMed ID: 29788895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants.
    Khandelwal N; Chander Y; Rawat KD; Riyesh T; Nishanth C; Sharma S; Jindal N; Tripathi BN; Barua S; Kumar N
    Antiviral Res; 2017 Aug; 144():196-204. PubMed ID: 28624461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial strategies: inhibition of viral polymerases by 3'-hydroxyl nucleosides.
    Deval J
    Drugs; 2009; 69(2):151-66. PubMed ID: 19228073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient random mutagenesis in transcription-reverse-transcription cycles by a hydrogen bond ambivalent nucleoside 5'-triphosphate analogue: potential candidates for a selective anti-retroviral therapy.
    Moriyama K; Otsuka C; Loakes D; Negishi K
    Nucleosides Nucleotides Nucleic Acids; 2001 Aug; 20(8):1473-83. PubMed ID: 11554540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isoprinosine: evaluation of its virus inhibiting action in vivo and in vitro].
    Eggers HJ; Neufahrt A; Rolly H
    Dtsch Med Wochenschr; 1972 Aug; 97(31):1156-9. PubMed ID: 4339680
    [No Abstract]   [Full Text] [Related]  

  • 17. Effective lethal mutagenesis of influenza virus by three nucleoside analogs.
    Pauly MD; Lauring AS
    J Virol; 2015 Apr; 89(7):3584-97. PubMed ID: 25589650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis.
    Harris KS; Brabant W; Styrchak S; Gall A; Daifuku R
    Antiviral Res; 2005 Jul; 67(1):1-9. PubMed ID: 15890415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity spectrum of phenoxazine nucleoside derivatives.
    Kozlovskaya LI; Andrei G; Orlov AA; Khvatov EV; Koruchekov AA; Belyaev ES; Nikolaev EN; Korshun VA; Snoeck R; Osolodkin DI; Matyugina ES; Aralov AV
    Antiviral Res; 2019 Mar; 163():117-124. PubMed ID: 30684562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C virus resistance to antiviral therapies--EASL-AASLD-APASL-ALEH-IASL conference.
    Buti M
    IDrugs; 2008 Apr; 11(4):239-41. PubMed ID: 18379952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.